openPR Logo
Press release

Disease Management Apps Market to Reach USD 33.39 Billion by 2034, Expanding at a CAGR of 11.7%

06-20-2025 12:26 PM CET | Health & Medicine

Press release from: polaris market reserch

Disease Management Apps Market

Disease Management Apps Market

Polaris Market Research announces the release of its latest research report titled, "Disease Management Apps Market Size, Share, Trends, & Industry Analysis Report: By Platform (iOS, Android, and Others), By Device, By Indication, and By Region - Market Forecast, 2025-2034."

The report analyzes the market to register a CAGR of 11.7% during 2025-2034. The market was valued at USD 11.10 billion in 2024 and is projected to grow to USD 33.39 billion by 2034.

Market Introduction:
Disease management apps are digital healthcare solutions that enable individuals to track, control, and enhance their health conditions more efficiently using smartphones, tablets, or other connected devices. These apps cater to a wide range of chronic and acute diseases. They typically offer features like medication reminders, symptom tracking, personalized health insights, and appointment scheduling. Also, they allow integration with wearable devices to collect real-time health data. Some advanced apps also use artificial intelligence and machine learning to provide predictive analytics, early warning alerts, or treatment suggestions based on user data.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/disease-management-apps-market/request-for-sample

Market Growth Drivers:
Increasing Prevalence of Chronic Disorders: The rising prevalence of chronic health conditions such as cardiovascular diseases, diabetes, and respiratory conditions is fueling the development of disease management apps. There is a growing need for continuous monitoring and personalized care outside traditional clinical settings. Disease management apps offer tailored health tracking, symptom logging, and medication reminders, which are highly beneficial for individuals managing long-term conditions.

Wider Access to Health Apps: The increased access to health apps has fueled the growth potential of disease management apps by improving their accessibility. With a majority of people now using smartphones globally, health apps have become more readily available across different demographic and geographic segments. The digital reach empowers individuals to monitor their health in real time, thereby driving market expansion.

Market Key Players:
The disease management apps market is undergoing rapid evolution. Major market participants are adopting several strategic initiatives to garner a larger market share. A few of the leading market players are:
• Athenahealth
• Epic Systems Corporation.
• F. Hoffmann-La Roche Ltd
• Innovaccer, Inc.
• IQVIA
• Lark Technologies, Inc.
• Mahalo Digital Ventures, Inc.
• Medisafe.
• Omada Health Inc.
• Oracle
• Pfizer Inc.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/disease-management-apps-market/request-for-discount-pricing

Disease Management Apps Market Report Highlights:
• In terms of platform, the Android segment led the market in 2024, owing to its extensive global adoption and cost-effective device options that improve accessibility.

• Based on device, the wearables segment is anticipated to experience the most rapid market expansion, fueled by increasing consumer demand for continuous health tracking and customized health data analytics.

• In 2024, North America accounted for the largest revenue share, benefiting from developed healthcare IT systems, widespread smartphone usage, and the concentration of top health tech companies and app developers.

Market Segmentation:
Disease Management Apps Market, Platform Outlook (Revenue - USD Billion, 2020-2034)
• iOS
• Android
• Others

Disease Management Apps Market, Device Outlook (Revenue - USD Billion, 2020-2034)
• Smartphones
• Tablets
• Wearables

Disease Management Apps Market, Indication Outlook (Revenue - USD Billion, 2020-2034)
• Obesity
• Cardiovascular Issues
• Diabetes
• Mental Health
• Others

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/disease-management-apps-market

Regional Assessment:
North America: North America led the global disease management apps market in 2024. The regional market dominance is primarily fueled by advanced digital health infrastructure and the robust presence of leading app developers and health technology firms. The early adoption of connected health solutions and telehealth has created a favorable environment for the growth of disease management applications.

Asia Pacific: Asia Pacific is projected to register the fastest growth from 2025 to 2034. This is primarily due to rapid digital transformation and growing awareness of chronic diseases in the region. In addition, a large and aging population base is boosting the demand for effective chronic disease management tools.
• North America
o Platform Outlook
 iOS
 Android
 Others

o Device Outlook
 Smartphones
 Tablets
 Wearables

o Indication Outlook
 Obesity
 Cardiovascular Issues
 Diabetes
 Mental Health
 Others

• Europe
o Platform Outlook
 iOS
 Android
 Others

o Device Outlook
 Smartphones
 Tablets
 Wearables

o Indication Outlook
 Obesity
 Cardiovascular Issues
 Diabetes
 Mental Health
 Others

• Asia Pacific
o Platform Outlook
 iOS
 Android
 Others

o Device Outlook
 Smartphones
 Tablets
 Wearables

o Indication Outlook
 Obesity
 Cardiovascular Issues
 Diabetes
 Mental Health
 Others

More Trending Latest Reports by Polaris Market Research:
Asia Pacific Gaucher Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-gaucher-disease-treatment-market

North America Gaucher Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/north-america-gaucher-disease-treatment-market

GLP-1 Receptor Agonist Market
https://www.polarismarketresearch.com/industry-analysis/glp-1-receptor-agonist-market

GLP-1 Market
https://www.polarismarketresearch.com/industry-analysis/glp-1-market

Fabry Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/fabry-disease-treatment-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Disease Management Apps Market to Reach USD 33.39 Billion by 2034, Expanding at a CAGR of 11.7% here

News-ID: 4075625 • Views:

More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and